|
Volumn 75, Issue 3, 2014, Pages 285-287
|
The endocannabinoid system and schizophrenia: Links to the underlying pathophysiology and to novel treatment approaches
a
VACHS
(United States)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMISULPRIDE;
ANANDAMIDE;
CANNABIDIOL;
CANNABINOID 1 RECEPTOR;
DRONABINOL;
ENDOCANNABINOID;
FATTY ACID AMIDASE;
NEUROLEPTIC AGENT;
ARTICLE;
CANNABIS USE;
CINGULATE GYRUS;
COGNITIVE DEFECT;
GENETIC LINKAGE;
GENETIC POLYMORPHISM;
HUMAN;
NONHUMAN;
PATHOPHYSIOLOGY;
POSITIVE SYNDROME;
POSITRON EMISSION TOMOGRAPHY;
PRIORITY JOURNAL;
PRODROMAL SYMPTOM;
PSYCHOSIS;
RECEPTOR DENSITY;
SCHIZOPHRENIA;
SCHIZOPHRENIFORM DISORDER;
CANNABINOID RECEPTOR AGONISTS;
CANNABINOIDS;
ENDOCANNABINOIDS;
HUMANS;
RECEPTORS, CANNABINOID;
SCHIZOPHRENIA;
|
EID: 84898737913
PISSN: 01606689
EISSN: None
Source Type: Journal
DOI: 10.4088/JCP.14ac08982 Document Type: Article |
Times cited : (9)
|
References (52)
|